Skip to main content
Fig. 3 | BMC Immunology

Fig. 3

From: Intranasal immunization with recombinant Toxoplasma gondii actin depolymerizing factor confers protective efficacy against toxoplasmosis in mice

Fig. 3

rTgADF-specific IgG antibody responses in the serum. Determination of IgG antibodies in serum samples collected from the immunized (different doses of rTgADF) and control mice (PBS) two weeks after the last immunization. Titers were the average of duplicate readings. Results are mean ± SD values (n = 8) for three independent experiments; *, P < 0.05 compared to the PBS group; #, P < 0.01 compared to the other immunized groups

Back to article page